Capital Wealth Planning LLC lessened its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 58.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,051,904 shares of the company's stock after selling 1,483,998 shares during the period. Procter & Gamble makes up about 1.0% of Capital Wealth Planning LLC's investment portfolio, making the stock its 26th largest holding. Capital Wealth Planning LLC's holdings in Procter & Gamble were worth $150,128,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PG. Entelevest LLC bought a new position in Procter & Gamble in the 4th quarter valued at approximately $210,000. Truepoint Inc. lifted its position in Procter & Gamble by 2.1% in the 4th quarter. Truepoint Inc. now owns 131,704 shares of the company's stock valued at $18,875,000 after acquiring an additional 2,687 shares in the last quarter. Gilpin Wealth Management LLC bought a new position in Procter & Gamble in the 4th quarter valued at approximately $206,000. Dorsey & Whitney Trust CO LLC lifted its position in Procter & Gamble by 0.9% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 47,724 shares of the company's stock valued at $6,839,000 after acquiring an additional 412 shares in the last quarter. Finally, Hamel Associates Inc. raised its stake in Procter & Gamble by 2.1% during the 4th quarter. Hamel Associates Inc. now owns 57,956 shares of the company's stock valued at $8,308,000 after buying an additional 1,208 shares during the last quarter. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Trading Up 0.5%
NYSE:PG opened at $149.36 on Thursday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The firm has a market capitalization of $347.80 billion, a price-to-earnings ratio of 21.84, a price-to-earnings-growth ratio of 6.38 and a beta of 0.39. Procter & Gamble Company has a one year low of $137.62 and a one year high of $167.25. The business has a fifty day moving average price of $144.44 and a 200-day moving average price of $147.70.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.56 by $0.03. The firm had revenue of $21.24 billion during the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.Procter & Gamble's revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Friday, April 24th were paid a $1.0885 dividend. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date was Friday, April 24th. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. Procter & Gamble's dividend payout ratio (DPR) is currently 63.60%.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on PG. The Goldman Sachs Group decreased their target price on shares of Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a research note on Wednesday, April 8th. Weiss Ratings reiterated a "hold (c)" rating on shares of Procter & Gamble in a research note on Friday, March 27th. Bank of America decreased their target price on shares of Procter & Gamble from $171.00 to $167.00 and set a "buy" rating for the company in a research note on Friday, April 10th. Raymond James Financial decreased their target price on shares of Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating for the company in a research note on Tuesday, April 14th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Procter & Gamble from $165.00 to $162.00 and set an "overweight" rating for the company in a research note on Friday, April 17th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $161.06.
View Our Latest Research Report on PG
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.